228 related articles for article (PubMed ID: 9707291)
21. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
22. GR46611 potentiates 5-HT1A receptor-mediated locomotor activity in the guinea pig.
O'Neill MF; Sanger GJ
Eur J Pharmacol; 1999 Apr; 370(2):85-92. PubMed ID: 10323255
[TBL] [Abstract][Full Text] [Related]
23. Moderate role of oxytocin in the pro-ejaculatory effect of the 5-HT1A receptor agonist 8-OH-DPAT.
de Jong TR; Neumann ID
J Sex Med; 2015 Jan; 12(1):17-28. PubMed ID: 25359190
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
Misane I; Johansson C; Ogren SO
Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333
[TBL] [Abstract][Full Text] [Related]
25. S 14506: novel receptor coupling at 5-HT(1A) receptors.
Milligan G; Kellett E; Dacquet C; Dubreuil V; Jacoby E; Millan MJ; Lavielle G; Spedding M
Neuropharmacology; 2001 Mar; 40(3):334-44. PubMed ID: 11166326
[TBL] [Abstract][Full Text] [Related]
26. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis.
Jackson DM; Wallsten CE; Jerning E; Hu PS; Deveney AM
Psychopharmacology (Berl); 1998 Oct; 139(4):300-10. PubMed ID: 9809851
[TBL] [Abstract][Full Text] [Related]
27. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347
[TBL] [Abstract][Full Text] [Related]
28. Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors.
Jerning E; Rosqvist S; Mohell N
J Recept Signal Transduct Res; 2002; 22(1-4):483-95. PubMed ID: 12503636
[TBL] [Abstract][Full Text] [Related]
29. Strain differences in the response to the 5-HT1A receptor agonist, 8-OH-DPAT.
Uphouse L; Maswood S; Jackson A; Brown K; Prullage J; Myers T; Shaheen F
Pharmacol Biochem Behav; 2002 Jun; 72(3):533-42. PubMed ID: 12175449
[TBL] [Abstract][Full Text] [Related]
30. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
[TBL] [Abstract][Full Text] [Related]
31. S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptors.
Newman-Tancredi A; Chaput C; Verrièle L; Millan MJ
Eur J Pharmacol; 1996 Jun; 307(1):107-11. PubMed ID: 8831111
[TBL] [Abstract][Full Text] [Related]
32. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181.
Hillegaart V; Ahlenius S
Br J Pharmacol; 1998 Dec; 125(8):1733-43. PubMed ID: 9886765
[TBL] [Abstract][Full Text] [Related]
33. Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes.
Alper RH; Nelson DL
Eur J Pharmacol; 1998 Feb; 343(2-3):303-12. PubMed ID: 9570480
[TBL] [Abstract][Full Text] [Related]
34. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.
Sugimoto Y; Kimura I; Watanabe Y; Yamada J
Biol Pharm Bull; 2001 Oct; 24(10):1191-4. PubMed ID: 11642331
[TBL] [Abstract][Full Text] [Related]
35. Dimerization of 8-OH-DPAT increases activity at serotonin 5-HT1A receptors.
Pauwels PJ; Dupuis DS; Perez M; Halazy S
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):404-10. PubMed ID: 9826061
[TBL] [Abstract][Full Text] [Related]
36. Buspirone enhances immobility in the forced swim test in mice.
Kitamura Y; Nagatani T
Pharmacol Biochem Behav; 1996 Nov; 55(3):445-51. PubMed ID: 8951987
[TBL] [Abstract][Full Text] [Related]
37. Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats.
Gilbert F; Dourish CT; Brazell C; McClue S; Stahl SM
Psychoneuroendocrinology; 1988; 13(6):471-8. PubMed ID: 2907164
[TBL] [Abstract][Full Text] [Related]
38. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
[TBL] [Abstract][Full Text] [Related]
39. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
40. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]